发明名称 |
Compounds and methods for modulating interaction between proteins and target nucleic acids |
摘要 |
Provided herein are antisense compounds and methods for recruiting one or more non-cleaving protein to a target nucleic acid in a cell. In certain instances such recruitment of a non-cleaving protein alters the function or activity of the target nucleic acid. In certain such instances, the target nucleic acid a pre-mRNA and the recruitment of the non-cleaving protein results in a change in splicing of the pre-mRNA. |
申请公布号 |
US9518259(B2) |
申请公布日期 |
2016.12.13 |
申请号 |
US201113703322 |
申请日期 |
2011.06.15 |
申请人 |
Ionis Pharmaceuticals, Inc. |
发明人 |
Rigo Frank;Bennett C. Frank;Krainer Adrian R.;Hua Yimin |
分类号 |
C12N15/11;A61K48/00;C12Q1/68;C12N15/113;C07H21/04 |
主分类号 |
C12N15/11 |
代理机构 |
Ionis Pharmaceuticals, Inc. Patent Dept. |
代理人 |
Ionis Pharmaceuticals, Inc. Patent Dept. |
主权项 |
1. A method of inducing exon skipping in a target pre-mRNA in a cell comprising contacting the cell with an antisense compound comprising a chemically modified oligonucleotide consisting of 18 linked nucleosides; and thereby inducing exon skipping in the pre-mRNA in the cell; wherein the antisense compound comprises:
a 5′-wing region consisting of 2 linked duplex stabilizing nucleosides; a 3′-wing region consisting of 2 linked duplex stabilizing nucleosides; and a central gap region located between the 5′-wing region and the 3′-wing region and consisting of 14 contiguous nucleosides comprising 2′-F modifications;wherein each duplex stabilizing nucleoside is a 2′-methoxyethyl (2′-MOE) nucleoside, andwherein the antisense compound is complementary to an intron of the target pre-mRNA. |
地址 |
Carlsbad CA US |